A long-term extension analysis of the ERASURE and FIXTURE studies recently published in the British Journal of Dermatology demonstrates the long-lasting efficacy and safety of secukinumab in patients with moderate-to-severe psoriasis. These data confirm the results of the long-term extension of the SCULPTURE study.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Hematologic oncology
Healing potential based on innovative research approaches
- International Vitiligo Task Force
Position paper on trends and current treatment options
- New secondary analysis
Ginkgo biloba alleviated mild neurocognitive deficits
- Journal Club
New real-world data on light urticaria
- Tuberculosis and smoking
Tobacco consumption increases the risk of recurrence and mortality
- Rare diseases: hATTR amyloidosis
What treatment options are available today?
- "Antimicrobial stewardship"
Recognize local wound infection and risk of systemic spread
- Acute bronchitis